Starigel Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2020.
2020 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Starigel Pharmaceutical Private Limited

Starigel Pharmaceutical Private Limited, a struck off private limited company, was established on 11 December 2020 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24299DL2020PTC374422. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ravi Pawar (Director), Sanjay Pawar (Director). It is based at A-13/B, Kh No.31/23/2, Harijan Basti, Sec-7, Palam Extn. New Delhi, Delhi, Delhi, 110045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299DL2020PTC374422

  • Registration Number

    374422

  • Incorporation Date

    11 December 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 2 Months
Company report

Starigel Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Starigel Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Starigel Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravi Pawar Director 11 Dec 2020 Current
Sanjay Pawar Director 11 Dec 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Starigel Pharmaceutical.

Enhance accessibility to Starigel Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Starigel Pharmaceutical revenue growth over time
Starigel Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Starigel Pharmaceutical?

Unlock access to Starigel Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Starigel Pharmaceutical?

Starigel Pharmaceutical has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Starigel Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Starigel Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Starigel Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    The activity Ravi Pawar was appointed as a Director was appointed as a Director on 11 Dec 2020 & has been associated with this company since 5 years 2 months . was completed.

  • Director Appointment

    The activity Sanjay Pawar was appointed as a Director was appointed as a Director on 11 Dec 2020 & has been associated with this company since 5 years 2 months . was completed.

  • Company Incorporation

    Progress on Starigel Pharmaceutical Private Limited was registered on 11 Dec 2020 with Roc Delhi & aged 5 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Starigel Pharmaceutical Private Limited?

The CIN of Starigel Pharmaceutical Private Limited is U24299DL2020PTC374422.

Where is Starigel Pharmaceutical Private Limited headquartered?

Starigel Pharmaceutical Private Limited is headquartered at A-13/B, Kh No.31/23/2, Harijan Basti, Sec-7, Palam Extn. New Delhi, Delhi, Delhi, 110045.

When was Starigel Pharmaceutical Private Limited incorporated?

Starigel Pharmaceutical Private Limited was incorporated on 11 December 2020.

Who are the current directors of Starigel Pharmaceutical Private Limited?

The current directors of Starigel Pharmaceutical Private Limited are

What is the primary industry of Starigel Pharmaceutical Private Limited?

The primary industry of Starigel Pharmaceutical Private Limited is Pharma.

Is Starigel Pharmaceutical Private Limited a listed company?

Starigel Pharmaceutical Private Limited is unlisted.

What is the capital structure of Starigel Pharmaceutical Private Limited?

The authorized capital of Starigel Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available